EFTA01436506.pdf

Subject: *New* DB Client Call: NextGen Sequencing Update - Hosted by Dan Leonard - Monday, Au ust 27 10am ET From: Martin Zeman Date: Wed, 22 Aug 2018 08:17:54 -0400 To: "Paul Barrett )" Cc: Xavier Avila Stewart Oldfield , Davide-A Sferrazza Paul — this call might be interesting for you. Please join Deutsche Bank for a Conference Call on Monday August 27, 2018 10am ET Nextgen Sequencing Update Hosted by: Dan Leonard Life Science Tools & Diagnostics Analyst With Guest Speaker: Elaine Mardis Co-Executive Director, Institute for Genomic Medicine at Nationwide EFTA01436506 Children's Hospital Topics: Deep dive into nextgen sequencing trends with a focus on clinical applications Relevant stocks include: ILMN, TMO, A, PKI, BIO, PACB US: Int Conf ID: 9336548 1 Week REPLAY: U.S: Intl Access Code: 9336548 This event may contain 'research' as defined in MIFID II (Directive 2014/65/- EU). Please indicate if your firm or organisation is subject to Article 13 of MIFID II and requires any documentation to ensure compliance with the Directive For disclosures pertaining to recommendations or estimates made on securities mentioned during this event please see the most recently published company report or visit our global disclosure look-up page on our website at https://research.db.com/Research/Disclosures/CompanySearch EFTA01436507 fcid:[email protected] Martin Zeman Director I Key Client Partners Deutsche Bank Wealth Management DB Securities Inc 345 Park Av nu 1.1 4-0. 04 New York, NY, USA Tel. Mobi Emai KCP products and services are intended and available only for persons who are sophisticated institutional investors within the meaning of the FINRA Rule 4512(C)(3), and who are capable of evaluating the strategies, characteristics and investment risks of, and exercising independent judgment in evaluating, the ideas and products discussed herein. Trades and transactions are subject to relevant internal approvals of DBSI or its affiliates prior to execution, and the execution of any transaction or idea discussed herein is conditional on your becoming a client of Deutsche Bank. Key Client Partners (KCP) products, investment ideas and solutions and related matters discussed herein are provided for discussion purposes only, and strictly on a non-advisory basis. The KCP Americas desk does not provide investment advice. The information set forth herein is confidential and personal to you and is being presented for your information and for discussion purposes only. Any reproduction and/or redistribution thereof (in whole or in part) or disclosure of its content without our written consent is strictly forbidden. This communication does not create any legally binding obligation on the part of DBSI or any of its affiliates. This communication may contain confidential and/or privileged information. If you are not the intended recipient (or have received this communication in error) please notify the sender immediately and destroy this communication. Any unauthorized copying, disclosure or distribution of the material in this communication is strictly forbidden. Please refer to https://db.com/disclosures for additional EU corporate and regulatory disclosures. EFTA01436508 Deutsche Bank does not render legal or tax advice, and the information contained in this communication should not be regarded as such. EFTA01436509